Deep Track Capital, LP - 31 Mar 2025 SCHEDULE 13G/A Report for Context Therapeutics Inc. Common Stock, $0.001 par value per share (CNTX)

Filing Manager
Deep Track Capital, LP
Reporting Manager
Deep Track Capital, LP
Security
Context Therapeutics Inc. Common Stock, $0.001 par value per share
Symbol
CNTX
Shares outstanding
89,714,087 shares
Disclosed Ownership
7,419,355 shares
Ownership
8.3%
Form type
SCHEDULE 13G/A
Filing time
15 May 2025, 08:38:17 UTC
Date of event
31 Mar 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Deep Track Capital, LP 8.3% 7,419,355 0 7,419,355 /s/ David Kroin David Kroin, Managing Member of the General Partner of the Investment Adviser
Deep Track Biotechnology Master Fund, Ltd. 8.3% 7,419,355 0 7,419,355 /s/ David Kroin David Kroin, Director
David Kroin 8.3% 7,419,355 0 7,419,355 /s/ David Kroin David Kroin